143 related articles for article (PubMed ID: 32281437)
21. Randomized trial of tacrolimus (Prograf) in combination with azathioprine or mycophenolate mofetil versus cyclosporine (Neoral) with mycophenolate mofetil after cadaveric kidney transplantation.
Johnson C; Ahsan N; Gonwa T; Halloran P; Stegall M; Hardy M; Metzger R; Shield C; Rocher L; Scandling J; Sorensen J; Mulloy L; Light J; Corwin C; Danovitch G; Wachs M; van Veldhuisen P; Salm K; Tolzman D; Fitzsimmons WE
Transplantation; 2000 Mar; 69(5):834-41. PubMed ID: 10755536
[TBL] [Abstract][Full Text] [Related]
22. Long-term safety of mycophenolate mofetil and cyclosporine: a review.
Buell C; Koo J
J Drugs Dermatol; 2008 Aug; 7(8):741-8. PubMed ID: 18720690
[TBL] [Abstract][Full Text] [Related]
23. Efficacy of mycophenolate mofetil as a remission induction therapy in antineutrophil cytoplasmic antibody: associated vasculitis-a meta-analysis.
Kuzuya K; Morita T; Kumanogoh A
RMD Open; 2020 Apr; 6(1):. PubMed ID: 32371435
[TBL] [Abstract][Full Text] [Related]
24. Relative efficacy and safety of tacrolimus, mycophenolate mofetil, and cyclophosphamide as induction therapy for lupus nephritis: a Bayesian network meta-analysis of randomized controlled trials.
Lee YH; Song GG
Lupus; 2015 Dec; 24(14):1520-8. PubMed ID: 26162684
[TBL] [Abstract][Full Text] [Related]
25. Tofacitinib for the treatment of lichen planopilaris: A case series.
Yang CC; Khanna T; Sallee B; Christiano AM; Bordone LA
Dermatol Ther; 2018 Nov; 31(6):e12656. PubMed ID: 30264512
[TBL] [Abstract][Full Text] [Related]
26. Hydroxychloroquine and lichen planopilaris: efficacy and introduction of Lichen Planopilaris Activity Index scoring system.
Chiang C; Sah D; Cho BK; Ochoa BE; Price VH
J Am Acad Dermatol; 2010 Mar; 62(3):387-92. PubMed ID: 20061052
[TBL] [Abstract][Full Text] [Related]
27. Mycophenolate mofetil versus methotrexate for vulvar lichen planus: A 10-year retrospective cohort study demonstrates comparable efficacy and tolerability.
Hrin ML; Bowers NL; Feldman SR; Huang WW; Pichardo RO
J Am Acad Dermatol; 2022 Aug; 87(2):436-438. PubMed ID: 34499996
[No Abstract] [Full Text] [Related]
28. Lichen planopilaris: retrospective study on the characteristics and treatment of 291 patients.
Babahosseini H; Tavakolpour S; Mahmoudi H; Balighi K; Teimourpour A; Ghodsi SZ; Abedini R; Ghandi N; Lajevardi V; Kiani A; Kamyab K; Mohammadi M; Daneshpazhooh M
J Dermatolog Treat; 2019 Sep; 30(6):598-604. PubMed ID: 30411987
[TBL] [Abstract][Full Text] [Related]
29. Tacrolimus and mycophenolate mofetil as second-line treatment in autoimmune hepatitis: Is the evidence of sufficient quality to develop recommendations?
Abdollahi M; Ekrami NK; Ghojazadeh M; Boezen HM; Somi M; Alizadeh BZ
World J Gastroenterol; 2020 Oct; 26(38):5896-5910. PubMed ID: 33132643
[TBL] [Abstract][Full Text] [Related]
30. Outcomes of multitarget therapy using mycophenolate mofetil and tacrolimus for refractory or relapsing lupus nephritis.
Choi CB; Won S; Bae SC
Lupus; 2018 May; 27(6):1007-1011. PubMed ID: 29448881
[TBL] [Abstract][Full Text] [Related]
31. Treatment of severe lichen planus with mycophenolate mofetil.
Frieling U; Bonsmann G; Schwarz T; Luger TA; Beissert S
J Am Acad Dermatol; 2003 Dec; 49(6):1063-6. PubMed ID: 14639385
[TBL] [Abstract][Full Text] [Related]
32. Mycophenolate mofetil and prednisolone therapy in children with steroid-dependent nephrotic syndrome.
Bagga A; Hari P; Moudgil A; Jordan SC
Am J Kidney Dis; 2003 Dec; 42(6):1114-20. PubMed ID: 14655181
[TBL] [Abstract][Full Text] [Related]
33. Efficacy and Safety of Mycophenolate Mofetil in Patients With Autoimmune Hepatitis and Suboptimal Outcomes After Standard Therapy.
Roberts SK; Lim R; Strasser S; Nicoll A; Gazzola A; Mitchell J; Siow W; Khoo T; Hamarneh Z; Weltman M; Gow P; Janko N; Tse E; Mishra G; Cheng EH; Levy M; Cheng W; Sood S; Skoien R; Mitchell J; Zekry A; George J; MacQuillan G; Wigg A; Stuart K; Sievert W; McCaughan G;
Clin Gastroenterol Hepatol; 2018 Feb; 16(2):268-277. PubMed ID: 29050991
[TBL] [Abstract][Full Text] [Related]
34. Lupus nephritis: induction therapy in severe lupus nephritis--should MMF be considered the drug of choice?
Rovin BH; Parikh SV; Hebert LA; Chan TM; Mok CC; Ginzler EM; Hooi LS; Brunetta P; Maciuca R; Solomons N
Clin J Am Soc Nephrol; 2013 Jan; 8(1):147-53. PubMed ID: 22879439
[TBL] [Abstract][Full Text] [Related]
35. Mycophenolate mofetil therapy in adult patients with recalcitrant atopic dermatitis.
Dias-Polak D; Bergman R; Avitan-Hersh E
J Dermatolog Treat; 2019 Feb; 30(1):49-51. PubMed ID: 29683760
[TBL] [Abstract][Full Text] [Related]
36. Mycophenolate mofetil versus methotrexate for prevention of graft-versus-host disease in people receiving allogeneic hematopoietic stem cell transplantation.
Kharfan-Dabaja M; Mhaskar R; Reljic T; Pidala J; Perkins JB; Djulbegovic B; Kumar A
Cochrane Database Syst Rev; 2014 Jul; 2014(7):CD010280. PubMed ID: 25061777
[TBL] [Abstract][Full Text] [Related]
37. Response to combination of mycophenolate mofetil, cyclosporin A and corticosteroid treatment in lupus nephritis patients with persistent proteinuria.
Kasitanon N; Boripatkosol P; Louthrenoo W
Int J Rheum Dis; 2018 Jan; 21(1):200-207. PubMed ID: 28901731
[TBL] [Abstract][Full Text] [Related]
38. Mycophenolate mofetil as adjunctive therapy to corticosteroids for the treatment of pyoderma gangrenosum: a case series and literature review.
Hrin ML; Bashyam AM; Huang WW; Feldman SR
Int J Dermatol; 2021 Dec; 60(12):e486-e492. PubMed ID: 33739458
[TBL] [Abstract][Full Text] [Related]
39. Mycophenolate mofetil-based, cyclosporine-free induction and maintenance immunosuppression: first-3-months analysis of efficacy and safety in two cohorts of renal allograft recipients.
Zanker B; Schneeberger H; Rothenpieler U; Hillebrand G; Illner WD; Theodorakis I; Stangl M; Land W
Transplantation; 1998 Jul; 66(1):44-9. PubMed ID: 9679820
[TBL] [Abstract][Full Text] [Related]
40. The association of mycophenolate mofetil and human herpes virus infection.
Yun JSW; Yap T; Martyres R; Kern JS; Varigos G; Scardamaglia L
J Dermatolog Treat; 2020 Feb; 31(1):46-55. PubMed ID: 30676825
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
